title: Biosimilars in IBD: hope or expectation?
authors.affiliation: Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands.
authors.forename: Krisztina B
authors.initials: KB
authors.lastname: Gecse
authors.forename: Reena
authors.initials: R
authors.lastname: Khanna
authors.forename: Gijs R
authors.initials: GR
authors.lastname: van den Brink
authors.forename: Cyriel Y
authors.initials: CY
authors.lastname: Ponsioen
authors.forename: Mark
authors.initials: M
authors.lastname: Löwenberg
authors.forename: Vipul
authors.initials: V
authors.lastname: Jairath
authors.forename: Simon P L
authors.initials: SP
authors.lastname: Travis
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
authors.forename: Brian G
authors.initials: BG
authors.lastname: Feagan
authors.forename: Geert R A M
authors.initials: GR
authors.lastname: D'Haens
mesh_terms: D059451:Biosimilar Pharmaceuticals / Q000009:adverse effects / Q000737:chemistry / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D013810:Therapeutic Equivalency; D016896:Treatment Outcome
chemical_list: D059451:Biosimilar Pharmaceuticals